Cargando…
MiR‐629 regulates hypoxic pulmonary vascular remodelling by targeting FOXO3 and PERP
Pulmonary arterial hypertension (PAH) is featured by the increase in pulmonary vascular resistance and pulmonary arterial pressure. Despite that abnormal proliferation and phenotypic changes in human pulmonary artery smooth muscle cells (HPASMCs) contributing to the pathophysiology of PAH, the under...
Autores principales: | Zhao, Mei, Chen, Ni, Li, Xuelian, Lin, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653446/ https://www.ncbi.nlm.nih.gov/pubmed/31240850 http://dx.doi.org/10.1111/jcmm.14385 |
Ejemplares similares
-
MiR-629 promotes human pancreatic cancer progression by targeting FOXO3
por: Yan, Haijiao, et al.
Publicado: (2017) -
miR-629 targets FOXO3 to promote cell apoptosis in gastric cancer
por: Li, Ming, et al.
Publicado: (2020) -
circSMAD2 inhibits the epithelial–mesenchymal transition by targeting miR-629 in hepatocellular carcinoma
por: Zhang, Xianwei, et al.
Publicado: (2018) -
MiR-629-5p Promotes Prostate Cancer Development and Metastasis by Targeting AKAP13
por: Liu, Yangzhou, et al.
Publicado: (2021) -
Upregulation of Serum miR-629 Predicts Poor Prognosis for Non-Small-Cell Lung Cancer
por: Liu, Fayong, et al.
Publicado: (2021)